Literature DB >> 24347362

Comprehensive integrated care for patients with sickle cell disease in a remote aboriginal tribal population in southern India.

Vivek Nimgaonkar1, Lakshmanan Krishnamurti, Hari Prabhakar, Nandakumar Menon.   

Abstract

BACKGROUND: Healthcare delivery for sickle cell disease (SCD) can be challenging, in low resource settings. We studied the feasibility of delivering comprehensive SCD care in a community-based network for remote, economically, and socially disadvantaged tribes in Gudalur, India. PROCEDURE: We reviewed medical records for all patients followed at the Gudalur Adivasi Hospital. We used published quality of care indicators to benchmark screening and routine healthcare maintenance.
RESULTS: We screened 9,646 individuals (60.4%) under the age of 30 of a population of 25,000 individuals. Of 111 active patients with SCD, 71% have had at least one annual comprehensive clinic visit at a median visit interval of 57 days. We provided pneumococcal immunization and penicillin prophylaxis to 56 (50%) patients and HU to 68 (61%). Median spleen size was 1 cm (range 1-6 cm), mean was Hb 9.3 g/dl and we reported a mean of 0.7 painful episodes/year. Premature deaths occurred in 19 patients at a median age of 23 years due to acute chest syndrome, sepsis, severe anemia, stroke, mesenteric infarction, puerperal sepsis, or sudden unexplained death. Healthcare maintenance met 11 of 17 published SCD quality of care indicators. Average cost was 1,343 Indian Rupees (INR) (approximately US$ 25) per hospitalization and 173 INR (approximately US$ 4) per clinic visit.
CONCLUSION: High quality comprehensive care for SCD can be delivered for a low income, aboriginal population in India through a community driven network of care. This model can serve as a template for healthcare delivery for SCD in low-income communities.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  India; community based; comprehensive care; sickle cell disease; tribal

Mesh:

Year:  2013        PMID: 24347362     DOI: 10.1002/pbc.24723

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

1.  Sickle cell disease in tribal populations in India.

Authors:  Roshan B Colah; Malay B Mukherjee; Snehal Martin; Kanjaksha Ghosh
Journal:  Indian J Med Res       Date:  2015-05       Impact factor: 2.375

Review 2.  Sickle cell disease in India: a scoping review from a health systems perspective to identify an agenda for research and action.

Authors:  Vineet Raman; Prashanth N Srinivas; Tanya Seshadri; Sangeetha V Joice
Journal:  BMJ Glob Health       Date:  2021-02

Review 3.  Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease.

Authors:  Thamal Darshana; David Rees; Anuja Premawardhena
Journal:  Orphanet J Rare Dis       Date:  2021-03-23       Impact factor: 4.123

Review 4.  Prevalence of Stroke in Asian Patients with Sickle Cell Anemia: A Systematic Review and Meta-Analysis.

Authors:  Sandip Kuikel; Robin Rauniyar; Sanjeev Kharel; Anil Bist; Subarna Giri; Sahil Thapaliya; Sunanda Paudel
Journal:  Neurol Res Int       Date:  2021-06-03

5.  Sickle cell disease in India: A perspective.

Authors:  Graham R Serjeant; Kanjaksha Ghosh; Jyotish Patel
Journal:  Indian J Med Res       Date:  2016-01       Impact factor: 2.375

Review 6.  Evolving locally appropriate models of care for indian sickle cell disease.

Authors:  Graham R Serjeant
Journal:  Indian J Med Res       Date:  2016-04       Impact factor: 2.375

7.  Attrition from Care and Clinical Outcomes in a Cohort of Sickle Cell Disease Patients in a Tribal Area of Western India.

Authors:  Kapilkumar Dave; Palanivel Chinnakali; Pruthu Thekkur; Shrey Desai; Chandrakant Vora; Gayatri Desai
Journal:  Trop Med Infect Dis       Date:  2019-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.